Tech Company Financing Transactions
Atritech Funding Round
On 3/8/2006, Atritech raised $22.5 million in investment from Prism VentureWorks and Tullis Health Investors.
Transaction Overview
Company Name
Announced On
3/8/2006
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Undisclosed
Investors
Prism VentureWorks (Lead Investor) (Gordie Nye)
Proceeds Purpose
With this capital, the Company will complete enrollment in the PROTECT AF clinical trial.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
3750 Annapolis Ln. 105
Plymouth, MN 55447
USA
Plymouth, MN 55447
USA
Phone
Website
Email Address
Overview
Atritech is an emerging medical device company focused on preventing atrial fibrillation (AF) related stroke through technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Bullock
VP - Finance
Brad Swatfager
VP - Marketing
Maggie Wallner
VP - Operations
Mike Costello
Browse more venture capital transactions:
Prev: 3/8/2006: Aegis Semiconductor venture capital transaction
Next: 3/9/2006: Ahura Scientific venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record all VC transactions involving tech companies. All VC database entries reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs